- PDF Version (100K) - Print Friendly - Help

AgVetLink, October 2004

GMP update

At the last AVMAC meeting on 19 August 2004, members agreed to participate in working groups that were being set up to review some policy issues with technical connections.

One of the issues proposed for consideration is the application of approvals of manufacturers of plant compounds for compliance with Good Manufacturing Practice (GMP). For many years manufacturers of veterinary medicines have been inspected and approved for GMP compliance against a New Zealand standard for GMP adopted from an international standard.

It is expected that the working group will review the similarities and differences between the agrichemicals and veterinary pharmaceuticals industries, and develop recommendations for AVMAC and the ACVM Group to consider. Dr Jack Richardson, Chief Executive of Agcarm, has agreed to coordinate the GMP Working Group.